Guidelines

ERS/ESTS/ESTRO/ESR/ESTI/EFOMP statement on management of incidental findings from low dose CT screening for lung cancer (MILCa)

Emma L. O'Dowd, Ilona Tietzova, Emily Bartlett, Anand Devaraj, Jürgen Biederer, Marco Brambilla, Alessandro Brunelli, Joanna Chorostowska-Wynimko, Herbert Decaluwe, Dirk Deruysscher, Walter De Wever, Matthew Donoghue, Aurelie Fabre, Mina Gaga, Wouter van Geffen, Georgia Hardavella, Hans-Ulrich Kauczor, Anna Kerpel-Fronius, Jan van Meerbeeck, Blin Nagavci, Ursula Nestle, Nuria Novoa, Helmut Prosch, Mathias Prokop, Paul Martin Putora, Janette Rawlinson, Marie-Pierre Revel, Annemiek Snoeckx, Gi

Year:

2023

Type:

Statement

Produced by:

ERS / ESTRO / ESTS / ESR / ESTI / EFOMP

European Respiratory Journal 2023 62: 2300533; DOI: 10.1183/13993003.00533-2023
Abstract
Background Screening for lung cancer with low radiation dose computed tomography has a strong evidence base, is being introduced in several European countries and is recommended as a new targeted cancer screening programme. The imperative now is to ensure that implementation follows an evidence-based process that will ensure clinical and cost effectiveness. This European Respiratory Society (ERS) task force was formed to provide an expert consensus for the management of incidental findings which can be adapted and followed during implementation.

Read more
Read less

Additional content

Webinar